Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.320
+0.010 (0.76%)
At close: Dec 5, 2025, 4:00 PM EST
1.298
-0.022 (-1.66%)
After-hours: Dec 5, 2025, 7:47 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2020FY 2019FY 20182001 - 2017
Period Ending
Dec '24 Dec '23 Dec '20 Dec '19 Dec '18 2001 - 2017
Cellular Therapies
582.00K
Log In
Log In
Log In
Log In
Upgrade
Cellular Therapies Growth
755.88%
Log In
Log In
Log In
Log In
Upgrade
Subscription
-
Log In
Log In
Log In
Log In
Upgrade
Subscription Growth
-
Log In
Log In
Log In
Log In
Upgrade
Sales-type Lease Revenue Hardware
-
Log In
Log In
Log In
Log In
Upgrade
Sales-type Lease Revenue Hardware Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2020FY 2019FY 20182001 - 2017
Period Ending
Dec '24 Dec '23 Dec '20 Dec '19 Dec '18 2001 - 2017
United States
582.00K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
755.88%
Log In
Log In
Log In
Log In
Upgrade
Canada
-
Log In
Log In
Log In
Log In
Upgrade
Canada Growth
-
Log In
Log In
Log In
Log In
Upgrade